Cypress Bioscience (CYPB) Reports Q1 Loss of $0.24
Cypress Bioscience, Inc. (NASDAQ: CYPB) reports Q1 loss of $0.24, versus the analyst estimate of $0.12 and compared to a loss of $0.08 in the same period last year. Revenue for the quarter was $7.9 million, versus the consensus of $14.61 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- NetApp (NTAP) Slammed On Weak Outlook
- Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
